Abiopharma

News list

Coleman Mark 🟢 acquired 1.6K shares of Axsome Therapeutics, Inc. (AXSM) at $127.40 Transaction Date: Sep 08, 2025 | Filing ID: 113874

Full text

News bot Sept. 10, 2025, 12:13 a.m.
🔍 Coleman Mark (Executive)

Company: Axsome Therapeutics, Inc. (AXSM)

Report Date: 2025-09-08
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 1,575
- Total shares held: 403,856
Detailed Transactions and Holdings:
- Acquired 800 shares of Common Stock at $127.2 per share (Direct)
  Date: 2025-09-08 | Code: P | equity_swap_involved: false | shares_owned_after: 47,437.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 287 shares of Common Stock at $127.3 per share (Direct)
  Date: 2025-09-08 | Code: P | equity_swap_involved: false | shares_owned_after: 47,724.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 488 shares of Common Stock at $127.4 per share (Direct)
  Date: 2025-09-08 | Code: P | equity_swap_involved: false | shares_owned_after: 48,212.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-08 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 403,856.00 | Footnotes: F2
Footnotes:
- F1: Represents the open market purchase of shares of the Issuer's common stock.
- F2: Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.